Home  »  News   »  Brickell Biotech Inc. (BBI) market price of $4.19 ...

Brickell Biotech Inc. (BBI) market price of $4.19 offers the impression of an exciting value play

For the readers interested in the stock health of Brickell Biotech Inc. (BBI). It is currently valued at $4.19. When the transactions were called off in the previous session, Stock hit the highs of $4.64, after setting-off with the price of $3.17. Company’s stock value dipped to $3.15 during the trading on the day. When the trading was stopped its value was $3.15.Recently in News on August 2, 2022, Brickell Biotech to Report Second Quarter 2022 Financial Results and Provide a Corporate Update on August 11, 2022. Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases, today announced that it will report its second quarter financial results on Thursday, August 11th. Brickell’s management will host a conference call and webcast at 4:30 p.m. EDT that same day to discuss the financial results and recent corporate highlights. You can read further details here

Brickell Biotech Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $18.94 on 04/19/22, with the lowest value was $2.88 for the same time period, recorded on 08/01/22.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Brickell Biotech Inc. (BBI) full year performance was -85.86%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Brickell Biotech Inc. shares are logging -88.78% during the 52-week period from high price, and 45.49% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.88 and $37.35.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1732149 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Brickell Biotech Inc. (BBI) recorded performance in the market was -59.32%, having the revenues showcasing -59.95% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 11.56M, as it employees total of 16 workers.

Analysts verdict on Brickell Biotech Inc. (BBI)

During the last month, 3 analysts gave the Brickell Biotech Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 1 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 8.13, with a change in the price was noted -6.84. In a similar fashion, Brickell Biotech Inc. posted a movement of -62.03% for the period of last 100 days, recording 207,694 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for BBI is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Brickell Biotech Inc. (BBI): Technical Analysis

Raw Stochastic average of Brickell Biotech Inc. in the period of last 50 days is set at 13.48%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 74.43%. In the last 20 days, the company’s Stochastic %K was 35.26% and its Stochastic %D was recorded 16.95%.

Let’s take a glance in the erstwhile performances of Brickell Biotech Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -59.32%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -63.43%, alongside a downfall of -85.86% for the period of the last 12 months. The shares increased approximately by 35.60% in the 7-day charts and went up by 5.28% in the period of the last 30 days. Common stock shares were lifted by -59.95% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts